AGArtiom Gruzdev

Artiom Gruzdev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Artiom Gruzdev has a total of 118 co-authors. Here are the top co-authors by number of shared publications:

  • Darryl C. Zeldin

    Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA

    6 shared publications
  • Matthew L. Edin

    Immunity, Inflammation, and Disease Laboratory, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA

    4 shared publications
  • Thomas B Hagler

    Gene Editing and Mouse Model Core Facility, National Institute of Environmental Health Sciences , North Carolina

    3 shared publications
  • Bairon Hernandez

    Centro de Bioinformática y Simulación Molecular, Facultad de Ingenieria, Universidad de Talca, Talca, Chile

    2 shared publications
  • Carmen J. Williams

    Affiliation Reproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina, United States of America

    2 shared publications
  • Dagoberto Grenet

    Genomic Integrity and Structural Biology Laboratory, National Institutes of Health, Durham, NC, USA

    2 shared publications

Latest Publications

  • A new constitutive Foxl2-Cre mouse model reveals Foxl2 -derived cell fate in reproductive and non-reproductive tissues

    by Barbara Nicol, Artiom Gruzdev, Ciro Amato, Chang Liu, Gregory J Scott, Thomas B Hagler, Manas K Ray, Humphrey Hung-Chang Yao

    FOXL2 is a highly conserved transcription factor that is essential for ovarian development and female fertility. In humans, FOXL2 mutations or deletions cause blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) leading to eyelid defects and, in BPES type I, primary ovarian insufficiency. BPES is also associated with a wide range of less common phenotypes such as craniofacial features, cleft palate, or heart defects. In this study, we generated a new constitutive Foxl2-Cre mouse model using CRISPR/Cas9 editing. Crossing Foxl2-Cre mice with Rosa-tdTomato reporter confirmed robust and specific labeling of FOXL2+ cells during fetal development. We provide a detailed characterization of the permanent labeling of cells that, at any time in development, expressed Foxl2, with a particular interest on organs associated with a spectrum of features identified in BPES patients. Our model effectively targeted key reproductive tissues, such as fetal ovarian somatic cells, including granulosa, interstitium and theca-cell precursors, the anterior pituitary, and mesenchymal cells of the uterus and oviduct. We also identified Foxl2-derived cells in the supporting-like cells of the testis, as well as in the peri-urethral cells of the external genitalia. Beyond the reproductive organs, Foxl2-derived cells were identified in several other tissues relevant to BPES, including the head, palate, and the outflow tract of the heart. Overall, this Foxl2-Cre model provides a new tool for reproductive organ studies, and our characterization of Foxl2-derived cell fate brings a new perspective into the potential roles of FOXL2 in the wide spectrum of clinical features associated with BPES.


  • COX ‐2‐Derived PGE 2 Modulates IL ‐17 Production by γδ T Cells During Allergic Lung Inflammation

    by Chiguang Feng, Hong Li, Daniel Menendez, Matthew L. Edin, Artiom Gruzdev, Joan P. Graves, Laura M. DeGraff, Xiaojiang Xu, Brian D. Bennett, Jian‐Liang Li, et al.

    Cyclooxygenase‐2 (COX‐2)‐derived prostaglandins (PGs) regulate differentiation of αβ T helper cells to Th2, Th9, and Th17 cell subsets during allergic lung inflammation. IL‐17, the signature cytokine of Th17 cells, is a critical regulator of allergic immunopathology. Most studies on IL‐17 have focused on Th17 cells, though T cells are the primary IL‐17‐producing lymphocyte subset. Unlike conventional αβ T cells, T cells preferentially colonize non‐lymphoid tissues, such as intestine and airway epithelia/mucosa. It remains unknown if COX‐2‐derived PGs regulate T cells during allergic lung inflammation. Herein, we examined how COX‐2‐derived PGs regulate T cells using in vivo and in vitro assays with COX‐2 +/+ and COX‐2 −/− mice and isolated T cells. COX‐2 disruption reduced bronchoalveolar lavage fluid (BALF) IL‐17A production during ovalbumin (OVA)‐induced allergic lung inflammation in vivo without altering the number of IL‐17A‐producing T cells. Isolated T cells produced IL‐17A upon restimulation with IL‐1β + IL‐23 ex vivo; however, T cells from COX‐2 −/− mice produced less IL‐17A than T cells from COX‐2 +/+ mice. Of multiple PGs tested, only PGE 2 significantly promoted IL‐1β + IL‐23‐induced IL‐17A production by T cells. Single cell RNA sequencing (scRNA‐seq) identified, and qPCR confirmed, that T cells express only two PGE 2 receptors (EP2 and EP4). Both EP2 and EP4 antagonists attenuated the PGE 2 ‐mediated increases in IL‐17A formation by T cells. Taken together, these data suggest that COX‐2‐derived PGE 2 enhances IL‐17A production in T cells in an EP2/EP4 dependent manner during allergic lung inflammation.

  • Open Access

    Beware of your “oocyte specific” Cre line: somatic cell Cre expression in several Zp3–Cre lines and the Gdf9–iCre transgenic line

    by Paula Stein, Chihiro Emori, Elizabeth Padilla-Banks, Lenka Radonova, Artiom Gruzdev, Masahito Ikawa, Carmen J Williams

    Several zona pellucida 3 (Zp3)-Cre driver mouse lines are used to enable conditional loss-of-function studies in oocytes. The Knowles Zp3-Cre line, currently maintained live at the Jackson Laboratory, is the most widely published. We recently found that the transgene expressed in the Knowles line contains a truncated metallothionein 1 (Mt1) sequence that is expressed at high levels in oocytes from transgenic mice. This finding led us to search for an alternative Zp3-Cre line that did not express an exogenous Mt1 transcript. We tested a second transgenic Zp3-Cre line and then created our own transgenic Zp3-Cre line, neither of which was oocyte-specific as documented by crossing to the tdTomato reporter line. Similar testing confirmed the exquisite oocyte specificity of the Knowles Zp3-Cre line. An alternative to Zp3-Cre is to use the growth differentiation factor 9 (Gdf9)-iCre line, which is reported to be oocyte-specific and expressed beginning at the primordial follicle stage. This line similarly showed high somatic tissue Cre expression. Reasoning that a knock-in approach would ensure oocyte specificity, we used a CRISPR/Cas9 approach to insert Cre into the endogenous Zp3-Cre locus. However, crosses of this knock-in line with tdTomato females revealed high somatic tissue expression. Both the Zp3-Cre knock-in and Gdf9-iCre alleles, when paternally inherited, induced Cre expression by the blastocyst stage, explaining the broad tissue distribution. We conclude that the Knowles Zp3-Cre transgenic line remains the best model for generating oocyte-specific expression, though investigators should be aware of the spurious Mt1 expression from the transgene.


  • Top Cited Papers
    Open Access

    NAPRT-mediated deamidated NAD biosynthesis enhances colon tissue resiliency and suppresses tumorigenesis

    by Xiaoyue Wu, Jason G. Williams, Haoyang Liang, Artiom Gruzdev, Joshua Hartsell, Jack Shpargel, Rabina Mainali, Yi Fang, Ming Ji, Caroline Duval, et al.

    Nicotinamide adenine dinucleotide (NAD) is synthesized through both amidated salvage and deamidated pathways. Although NAD-producing enzymes are often overexpressed in cancer cells to meet the high metabolic demands of rapid proliferation and are considered oncogenic, we report that physiological levels of nicotinic acid phosphoribosyl transferase (NAPRT), the first enzyme in the Preiss-Handler arm of the deamidated pathways, suppress tumorigenesis. We show that NAPRT is enriched in gut epithelial cells, where it sustains the NAD pool for an efficient response to stress-induced acute NAD depletion. Consequently, NAPRT deficiency impairs the activity of poly-(ADP-ribose) polymerases and DNA repair, sensitizes mice to chemical-induced colitis and tumorigenesis, as well as to age-associated spontaneous tumor development. Moreover, low NAPRT expression correlates with poor prognosis in several human cancer types. Thus, homeostatic levels of deamidated NAD biosynthesis contribute to tumor suppression, and boosting this pathway may offer a strategy for cancer prevention.


  • Open Access

    Conplastic FVB/N-mt129S6/SvEvTac mice: A new tool for cancer research

    by Artiom Gruzdev, Wendy N. Jefferson, Thomas B. Hagler, Gregory J. Scott, Manas K. Ray, Ginger W. Muse, Rani S. Sellers, Carmen J. Williams

    FVB/N mice, which are commonly used for cancer studies, have accelerated onset of endometrial cancer following developmental estrogenic chemical exposure. These mice also have a polymorphism in the mitochondrial gene, mt-Atp8 , leading to increased production of reactive oxygen species. We hypothesized that this polymorphism contributes to the enhanced endometrial cancer phenotype in FVB/N mice. To test this idea, we generated conplastic FVB/N-mt129S6/SvEvTac mice (FVB/N nuclear genome; 129S6/SvEvTac mitochondria: FVB/N-mt129). The impact of 129S6 versus FVB/N mitochondrial genomes on endometrial cancer development following neonatal exposure to the xenoestrogen, diethylstilbestrol, was tested by comparing the cancer phenotypes of FVB/N mice to FVB/N-mt129 mice. There was no difference in cancer incidence regardless of mitochondria source, but cancer grade was higher in the conplastic strain. Additionally, while the FVB/N genetic background is considered non-permissive for generation of pluripotent mouse embryonic stem cells, blastocysts from the conplastic background readily generated mouse embryonic stem cell clones that supported gene editing in culture and subsequently generated germline competent chimeric founder mice. FVB/N-mt129 mice are a potentially powerful resource for generating germline competent embryonic stem cells with an FVB/N nuclear genome and for studying cancer phenotypes.

  • Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness

    by Gregory S Whitehead, Keiko Nakano, Christina L Wilkinson, Antonio M Patterson, Sandeep Upadhyay, Abdull J Massri, Brian N Papas, Artiom Gruzdev, Manas Ray, Hideki Nakano, et al.

    Rationale: The urokinase plasminogen activator receptor (uPAR) is a membrane-bound protein that can contribute to the activation and mobilization of leukocytes and is present at increased levels in asthmatics. However, its role in allergic asthma remains poorly understood. Methods: We used multiple mouse strains and different models of allergic airway disease to study the function of uPAR in the pathogenesis of this disease. Measurements and Main Results: Plaur, the gene encoding uPAR, was rapidly induced following allergic sensitization through the airway and again following subsequent allergen challenge. Plaur-deficient mice displayed both increased numbers of eosinophils and heightened airway hyperresponsiveness (AHR) in multiple models of allergic asthma. Mice selectively lacking Plaur in eosinophils also had more robust eosinophilia than did wild-type (WT) mice, and eosinophils lacking Plaur displayed increased activity in an ex vivo assay of chemokine-dependent migration. However, those mice did not have increased AHR compared with WT mice. Conversely, although mice selectively lacking Plaur in lung epithelial cells did not have increased inflammation compared with WT mice, they displayed heightened AHR. Conclusions: These findings suggest that uPAR controls both airway inflammation and AHR, but through distinct mechanisms. Targeting uPAR might have therapeutic potential for treating inflammation and AHR in asthma.

  • Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS‐CoV ‐2‐infected mice

    by Matthew L. Edin, Artiom Gruzdev, Joan P. Graves, Fred B. Lih, Christophe Morisseau, James M. Ward, Bruce D. Hammock, Catharine M. Bosio, Darryl C. Zeldin

    Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection involves an initial viral infection phase followed by a host‐response phase that includes an eicosanoid and cytokine storm, lung inflammation and respiratory failure. While vaccination and early anti‐viral therapies are effective in preventing or limiting the pathogenic host response, this latter phase is poorly understood with no highly effective treatment options. Inhibitors of soluble epoxide hydrolase (sEH) increase levels of anti‐inflammatory molecules called epoxyeicosatrienoic acids (EETs). This study aimed to investigate the impact of sEH inhibition on the host response to SARS‐CoV‐2 infection in a mouse model with human angiotensin‐converting enzyme 2 (ACE2) expression. Mice were infected with SARS‐CoV‐2 and treated with either vehicle or the sEH inhibitor 1‐trifluoromethoxyphenyl‐3‐(1‐propionylpiperidin‐4‐yl) urea (TPPU). At day 5 post‐infection, SARS‐CoV‐2 induced weight loss, clinical signs, a cytokine storm, an eicosanoid storm, and severe lung inflammation with ~50% mortality on days 6–8 post‐infection. SARS‐CoV‐2 infection induced lung expression of phospholipase A 2 (PLA 2 ), cyclooxygenase (COX) and lipoxygenase (LOX) pathway genes, while suppressing expression of most cytochrome P450 genes. Treatment with the sEH inhibitor TPPU delayed weight loss but did not alter clinical signs, lung cytokine expression or overall survival of infected mice. Interestingly, TPPU treatment significantly reversed the eicosanoid storm and attenuated viral‐induced elevation of 39 fatty acids and oxylipins from COX, LOX and P450 pathways, which suggests the effects at the level of PLA 2 activation. The suppression of the eicosanoid storm by TPPU without corresponding changes in lung cytokines, lung inflammation or mortality reveals a surprising dissociation between systemic oxylipin and cytokine signaling pathways during SARS‐CoV‐2 infection and suggests that the cytokine storm is primarily responsible for morbidity and mortality in this animal model.


  • Open Access

    TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation

    by Hong Li, J. Alyce Bradbury, Matthew L. Edin, Artiom Gruzdev, Huiling Li, Joan P. Graves, Laura M. DeGraff, Fred B. Lih, Chiguang Feng, Erin R. Wolf, et al.

    In lung, thromboxane A 2 (TXA 2 ) activates the TP receptor to induce proinflammatory and bronchoconstrictor effects. Thus, TP receptor antagonists and TXA 2 synthase inhibitors have been tested as potential asthma therapeutics in humans. Th9 cells play key roles in asthma and regulate the lung immune response to allergens. Herein, we found that TXA 2 reduces Th9 cell differentiation during allergic lung inflammation. Th9 cells were decreased approximately 2-fold and airway hyperresponsiveness was attenuated in lungs of allergic mice treated with TXA 2 . Naive CD4 + T cell differentiation to Th9 cells and IL-9 production were inhibited dose-dependently by TXA 2 in vitro. TP receptor–deficient mice had an approximately 2-fold increase in numbers of Th9 cells in lungs in vivo after OVA exposure compared with wild-type mice. Naive CD4 + T cells from TP-deficient mice exhibited increased Th9 cell differentiation and IL-9 production in vitro compared with CD4 + T cells from wild-type mice. TXA 2 also suppressed Th2 and enhanced Treg differentiation both in vitro and in vivo. Thus, in contrast to its acute, proinflammatory effects, TXA 2 also has longer-lasting immunosuppressive effects that attenuate the Th9 differentiation that drives asthma progression. These findings may explain the paradoxical failure of anti-thromboxane therapies in the treatment of asthma.


  • Chromatin architectural factor CTCF is essential for progesterone‐dependent uterine maturation

    by Sylvia C. Hewitt, Artiom Gruzdev, Cynthia J. Willson, San‐Pin Wu, John P. Lydon, Niels Galjart, Francesco J. DeMayo

    Receptors for estrogen and progesterone frequently interact, via Cohesin/CTCF loop extrusion, at enhancers distal from regulated genes. Loss‐of‐function CTCF mutation in >20% of human endometrial tumors indicates its importance in uterine homeostasis. To better understand how CTCF‐mediated enhancer‐gene interactions impact endometrial development and function, the Ctcf gene was selectively deleted in female reproductive tissues of mice. Prepubertal Ctcf d/d uterine tissue exhibited a marked reduction in the number of uterine glands compared to those without Ctcf deletion ( Ctcf f/f mice). Post‐pubertal Ctcf d/d uteri were hypoplastic with significant reduction in both the amount of the endometrial stroma and number of glands. Transcriptional profiling revealed increased expression of stem cell molecules Lif , EOMES, and Lgr5 , and enhanced inflammation pathways following Ctcf deletion. Analysis of the response of the uterus to steroid hormone stimulation showed that CTCF deletion affects a subset of progesterone‐responsive genes. This finding indicates (1) Progesterone‐mediated signaling remains functional following Ctcf deletion and (2) certain progesterone‐regulated genes are sensitive to Ctcf deletion, suggesting they depend on gene‐enhancer interactions that require CTCF. The progesterone‐responsive genes altered by CTCF ablation included Ihh , Fst, and Errfi1 . CTCF‐dependent progesterone‐responsive uterine genes enhance critical processes including anti‐tumorigenesis, which is relevant to the known effectiveness of progesterone in inhibiting progression of early‐stage endometrial tumors. Overall, our findings reveal that uterine Ctcf plays a key role in progesterone‐dependent expression of uterine genes underlying optimal post‐pubertal uterine development.


  • Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function

    by Deanna K. Sosnowski, K. Lockhart Jamieson, Artiom Gruzdev, Yingxi Li, Robert Valencia, Ala Yousef, Zamaneh Kassiri, Darryl C. Zeldin, John M. Seubert

    The cardioprotective effects of genetic disruption and pharmacological inhibition of sEH have been demonstrated in a variety of cardiac disease models, including acute LPS inflammatory injury. For the first time, it has been demonstrated that sEH genetic disruption limited to the cardiomyocyte profoundly preserves cardiac function and limits local and systemic inflammation following acute LPS exposure. Hence, cardiomyocytes serve a critical role in the innate immune response that can be modulated to protect the heart.